PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
Technical advances in radiotherapy (RT) treatment planning and delivery have substantially changed RT concepts for primary prostate cancer (PCa) by (i) enabling a reduction of treatment time, and by (ii) enabling safe delivery of high RT doses. Several studies proposed a dose–response relationship f...
Saved in:
Main Authors: | Constantinos Zamboglou, Simon K. B. Spohn, Sonja Adebahr, Maria Huber, Simon Kirste, Tanja Sprave, Christian Gratzke, Ronald C. Chen, Ernst Günther Carl, Wolfgang A. Weber, Michael Mix, Matthias Benndorf, Thomas Wiegel, Dimos Baltas, Carolin Jenkner, Anca L. Grosu |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/61b329409a6840e38e51365c8dece786 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Volumetric Response of Limited Brain Metastatic Disease to Focal Hypofractionated Radiation Therapy
by: Asanka R. Wijetunga, et al.
Published: (2021) -
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
by: Jorgo Kliton, et al.
Published: (2021) -
Treatment options and outcomes for glioblastoma in the elderly patient
by: Arvold ND, et al.
Published: (2014) -
Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
by: John Yeakel, MD, et al.
Published: (2021) -
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
by: Huayong Jiang, et al.
Published: (2021)